Guangzhou
China
6
2019-05-16
6
2020-05-26
These are the the leading inventors for applications assigned to Curegenix, Inc.:
Curegenix, Inc. based in Guangzhou, CN has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Compounds for treatment of cancer
#2 | 2019-01-24 ✅ Patent 10,702,473 granted on 2020-07-07Liposome formulation for delivery of Wnt signal pathway inhibitor
#3 | 2016-01-07 ✅ Patent 9,713,612 granted on 2017-07-25Compounds for treatment of cancer
#4 | 2016-01-07 ✅ Patent 9,744,169 granted on 2017-08-29Compounds for treatment of fibrosis diseases
#5 | 2015-04-30 ✅ Patent 9,556,144 granted on 2017-01-31Compound as WNT signaling inhibitor, composition, and use thereof
#6 | 2014-01-30 ✅ Patent 8,785,442 granted on 2014-07-22Compound as antagonist of lysophosphatidic acid receptor, composition, and use thereof
Also check out Curegenix, Inc.'s (Guangzhou, China) applicant profile with 2 patent applications submitted.
481775 ⎘